Silverberg, J. I., M. Cork, A. Wollenberg, N. Katoh, L. A. Steffensen, A. Kurbasic, C. K. Olsen, A. Kuznetsova, M. L. ?sterdal, A. W. Vilsb?ll, and M. Deleuran. “Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s98, doi:10.25251/skin.4.supp.98.